Diabetes

PITTSBURGH — Mylan and Biocon have a deal to develop and sell generic insulin-analog products for diabetes, Mylan said.

Under the deal, Mylan will have the rights to develop and market Biocon's Glargine, Lispro and Aspart, respectively generic versions of Sanofi's Lantus, Eli Lilly's Humalog and Novo Nordisk's NovoLog.

HYDERABAD, India — The Food and Drug Administration has approved a generic diabetes drug made by Aurobindo Pharma, the drug maker said.

Aurobindo announced the approval of pioglitazone tablets in the 15 mg, 30 mg and 45 mg strengths, in addition to the earlier tentative approval it received for pioglitazone and metformin hydrochloride tablets in the 15 mg/500 mg and 15 mg/850 mg strengths.

BAGSVÆRD, Denmark — The Food and Drug Administration declined to approve two insulin products made by Danish drug maker Novo Nordisk, the company said Sunday.

Novo Nordisk said it received complete response letters from the FDA for Tresiba (insulin degludec) and Ryzodeg (insulin degludec and insulin aspart). The FDA issues a complete response letter when it has finished reviewing an application for a drug, but determines that the application can't be approved in its current form.

PHILADELPHIA — While much of the attention to diabetes has focused on the dramatic rise of Type 2 diabetes among adults and children alike, a new study by a researcher in Philadelphia has found a spike in Type 1 diabetes among children as well.

SILVER SPRING, Md. - The Food and Drug Administration has approved a generic diabetes drug made by Macleods Pharma, according to agency records.

The FDA approved Macleods' pioglitazone hydrochloride tablets in the 15 mg, 30 mg and 45 mg strengths.

The drug is a generic version of Takeda's Actos, branded and generic versions of which had sales of about $2.7 billion during the 12-month period that ended in August 2012, according to IMS Health.

BENTONVILLE, Ark. — Sam's Club will offer free heart health screenings at 563 of its stores on Saturday, the club retailer said.

The screenings, taking place at stores with pharmacies, will include tests valued at up to $100 for glucose, total cholesterol, high-density lipoprotein cholesterol, blood pressure, body mass index and vision screenings.

INDIANAPOLIS — Adults living with diabetes in the United States reported highest satisfaction using Roche Diabetes Care's Accu-Chek products compared with other blood-glucose-meter manufacturers, according to the inaugural J.D. Power and Associates 2012 Blood Glucose Meter Satisfaction Study released Tuesday. 

The study gathered responses from 2,681 current meter users with type 1 and 2 diabetes in the U.S. to determine customer satisfaction across six factors: performance; ease of use; design; features; cost of test strips; and training.

ARLINGTON, Va. — A university research project to look at the potential effects on patient health of incorporating medication management strategies into existing care teams has won a grant from the National Association of Chain Drug Stores' philanthropic arm.

The NACDS Foundation said it gave the University of Nebraska Medical Center one of three research grants for the project, which will look at the effects of the strategies when they're incorporated into teams such as medical homes and accountable care organizations.